Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology Customers to benefit from simplified, scalable solutions for intensified cell culture Göttingen, Germany and Waltham, MA, USA — Sartorius Stedim Biotech (SSB) (Euronext: DIM), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation (NASDAQ:RGEN), a global life sciences company focused […]

Sydney, Australia, and Utrecht, the Netherlands MILabs announces that it has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney. Recognizing that excellence in research is increasingly linked to excellence in infrastructure capability, Sydney Imaging selected MILabs X-ray CT system for its unprecedented dose-efficiency […]

Greiner Bio-One North America, Inc. is proud to announce the launch of a new line of Erlenmeyer Shaker Flasks. These flasks are a welcomed new addition to the already robust cell culture product grouping provided by Greiner Bio-One which provides pharmaceutical and research laboratories with all the products they would need to perform cell culture […]

Greiner Bio-One North America, Inc. is proud to announce the launch of a new line of Erlenmeyer Shaker Flasks. These flasks are a welcomed new addition to the already robust cell culture product grouping provided by Greiner Bio-One which provides pharmaceutical and research laboratories with all the products they would need to perform cell culture […]

Emeryville, Calif. Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that Michel Sadelain, M.D., Ph.D., has been appointed a member of its Strategic Scientific Advisory Board (SSAB).  Dr. Sadelain joins other renowned experts with deep domain knowledge and insight on the SSAB and provides a strategic resource as BLI continues to expand […]

Two innovative companies with unique technologies unite, creating powerful tools for researches and companies developing the treatments of tomorrow. During recent years, 3D-Bioprinting has emerged as a powerful cell culture technology but has also been hampered by the lack of a biologically relevant Bioink. Today, CELLINK launches a brand new Bioink containing BIOLAMININS, that will […]

AMSBIO produce a growing range of experimental cell lines, recombinant proteins and screening services to advance the search for new Chimeric Antigen Receptor (CAR T) cell therapies to treat cancers. For years, the foundations of cancer treatment were surgery, chemotherapy, and radiation therapy. Over the last twenty years, therapeutic drugs that target cancer cells by homing in […]

RESEARCH TRIANGLE PARK, N.C.–Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today the first commercial sale of its automated AIR™ System for the imaging, sorting and isolation of single cells and small colonies. Albert Einstein College of Medicine investigator Jan Vijg, PhD, acquired the […]

NEWARK, Calif. — ATUM (formerly DNA2.0 Inc.), a pioneer in bioengineering solutions, announce the issuance of patent No. 10,041,077 by the U.S. Patent and Trademark Office (USPTO) for expanding the scope of Leap-In, the company’s innovative transposon-based tool. The patent entitled “DNA vectors, transposons and transposases for eukaryotic genome modification,” covers configurations of vectors and […]

BOULDER, Colo.–MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska. The funding supports the refinement of the MBio platform and improvements in manufacturing as […]